RIGVIR® is registered by the State Agency of Medicines of the Republic of Latvia, becoming the first approved oncolytic virotherapy medication.
Rigvir Group
Address: 9-7 Teatra street, LV–1050, Riga, Latvia
Phone: +371 67 229 599
E-mail: pr@rigvir.com